Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia

por Yu, Zhi-min, Zhao, Ying, Zhan, Jin-qiong, Luo, Tao, Xiong, Jian-wen, Yu, Bin, Wei, Bo, Yang, Yuan-jian
Publicado 2019

Erratum to: Changes of Serum Insulin-like Growth Factor-2 Response to Negative Symptom Improvements in Schizophrenia Patients Treated with Atypical Antipsychotics

por Chao, Xue-lin, Jiang, Shu-zhen, Xiong, Jian-wen, Zhan, Jin-qiong, Wei, Bo, Chen, Chun-nuan, Yang, Yuan-jian
Publicado 2020

Increased Plasma Level of Longevity Protein Klotho as a Potential Indicator of Cognitive Function Preservation in Patients With Schizophrenia

por Xiong, Jian-wen, Zhan, Jin-qiong, Luo, Tao, Chen, Hai-bo, Wan, Qi-gen, Wang, Yan, Wei, Bo, Yang, Yuan-jian
Publicado 2020

Altered insulin-like growth factor-2 signaling is associated with psychopathology and cognitive deficits in patients with schizophrenia

por Yang, Yuan-Jian, Luo, Tao, Zhao, Ying, Jiang, Shu-Zhen, Xiong, Jian-Wen, Zhan, Jin-Qiong, Yu, Bin, Yan, Kun, Wei, Bo
Publicado 2020

Decreased Plasma Levels of Growth Differentiation Factor 11 in Patients With Schizophrenia: Correlation With Psychopathology and Cognition

por Yang, Zhao-xi, Zhan, Jin-qiong, Xiong, Jian-wen, Wei, Bo, Fu, Yong-hui, Liu, Zhi-peng, Tu, Ya-ting, Yang, Yuan-jian, Wan, Ai-lan
Publicado 2020